• Care Mag Search: Drugs

      Receive the "Drugs" Newsletter by email

  • FDA Panel Backs GSK's RSV Vaccine for Older People

    23 days ago - By Time

    GSK Plc's vaccine for respiratory syncytial virus won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV.
    The panel of 12 outside advisers to the Food and Drug Administration voted unanimously on Wednesday that GSK's data show the Arexvy vaccine is effective. The same committee voted 10-2 that company data show the shot is safe. By contrast, it had voted 7-4 with one abstention to recommend Pfizer's vaccine as both safe and effective in preventing RSV.

    The...
    Read more ...

     

  • STAT+: Pharmalittle: FDA panel backs a GSK vaccine for RSV; opioid wholesalers cleared of liability to Georgia families

    23 days ago - By STAT

    Everyone, and how are you this morning? A spot of rain is falling on the Pharmalot campus, making for a gloomy start to yet another busy day. The official mascot, for instance, is put off - instead of gallivanting about the grounds, he remains curled up in a ball alongside us. Nonetheless, our spirits remain sunny. How so? We will trot a favorite bit of wisdom from the Morning Mayor: Every new day should be unwrapped like a precious gift. With this in mind, we are brewing another cup of stimulation - our choice today is chocolate raspberry - and unfurling our to-do list. Have a good day...
    Read more ...